ENTITY
Gilead Sciences

Gilead Sciences (GILD US)

142
Analysis
Health CareUnited States
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes therapeutics to advance the care of patients suffering from life-threatening diseases. The Company's primary areas of focus include HIV/AIDS, liver disease and serious cardiovascular and respiratory conditions.
more
Refresh
bullishGilead Sciences
27 Dec 2015 07:18

Thoughts on GILD – a Deep-Valued Growth Stock!

I see Gilead Sciences, Inc. as deep valued growth stock with very large margin of safety over the medium long term. Any sell-off along with the...

Logo
348 Views
Share
08 Dec 2015 11:42

Investing in the Internet of Things (IoT)

In today's digitized world, everything is connected and  'smart' - our phones are packed with ever more functionality, we can surf the net directly...

Logo
1.3k Views
Share
12 Nov 2015 09:34

Healthcare Observer: As Long-Term Patent Exposure Ebbs, Innovation in Big Pharma Pipelines Support

Pipeline innovation outpacing patent losses represents a core element of the wide moat ratings for most of the Big Pharma firms. Slowing patent...

Logo
317 Views
Share
11 Oct 2015 23:13

HILLARY! Scourge of Wall, Savior of Main - Preventer of Market Crashes, and Economic Crises

On October 8th, Hillary Clinton offered an Op-Ed on Bloomberg Views (available on the website here) which was a shorter version of...

Logo
297 Views
Share
09 Oct 2015 02:02

Many (un)happy returns in EM; governance and the vicious circle

This report examines the underlying governance factors that have driven EM underperformance over the last five years.Brazil, Russia, Malaysia and...

Share
x